Kelsey Barrell

Dr. Anzai is Professor of Radiology at the University of Utah. She completed her Diagnostic Radiology residency and neuroradiology fellowship training at the University of Michigan. In 2000, she moved to the University of Washington, Seattle where she had served as the neuroradiology fellowship director from 2004-2008, subsequently became the section chief in 2008. In 2005, she obtained her MPH from the University of Washington in Health Services funded by GERRAF program and AHRQ K08 award. Dr. Anzai currently serves as Associate Chief Medical Quality Officer of the University of Utah Health Care. The major goals as the Associate Chief Medical Quality Officer are to improve safety and quality of patient care, to facilitate the process standardization and coordination of care, to implement patient centered outcomes measures that are relevant for each service line, and connect the costs of delivering care with outcome measures in the entire healthcare enterprise. She received the AAMC (Associations of American Medical College) Award for the implementation of Value Driven Outcome tool in 2016. Dr. Anzai has been a longstanding member of many academic organizations, including ASNR, ASHNR, RSNA, AUR, ACR, and AAWR. She also participated in the large clinical trial including ACRIN trial. She has over 16 years of experience in working as a neuroradiologist in leading academic institutions with a background of health services research. Her area of primary imaging research interest includes head and neck cancer imaging, traumatic brain injury, and neurodegenerative disease. She is also involved in the cost effectiveness and comparative effectiveness of diagnostic tests in various conditions.

Dr. Amir M. Arain is a professor and an epileptologist that focuses on treatment of refractory epilepsy. He graduated from Dow Medical College, Karachi and did his Neurology residency and Epilepsy fellowship at Vanderbilt University. There he served on the faculty of Department of Neurology as an epileptologist from 2000-2018. He joined University of Utah in July 2018 and currently serves as chief of Epilepsy division. Dr. Arain has been involved in different research projects in epilepsy. He has done several antiepileptic drug trials including levetiracetam, oxcarbazepine, pregabalin, lacosemide, retigabine, brivaracetam, carisbamate, eslicarbazepine and cenobamate. He has published several peer reviewed research articles and has presented data in different scientific meetings. He has trained more than 100 fellows in epilepsy over the years. His interest is in seizure semiology, SUDEP, disparity of care in epilepsy and Geriatric epilepsy.

Dr. Ameena Husain is an Assistant Professor in the Division of Neonatology. She received her medical degree from Touro University Nevada, completed her Pediatric Residency at Advocate Children’s Hospital in Oak Lawn, IL, and her Neonatal-Perinatal Medicine Fellowship at Washington University in St. Louis, MO. Dr. Husain is board certified in Pediatrics and board eligible for Neonatal-Perinatal Medicine. Dr. Husain provides Neonatology services at the University of Utah Hospital, Primary Children’s Hospital, and Intermountain Medical Center. She cares for both premature and critically ill infants as well as infants with a variety of birth defects. Her clinical interest is in biomedical informatics, specifically related to the use of the electronic medical record.